Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 22

1.

Comparison of a four-drug fixed-dose combination regimen with a single tablet regimen in smear-positive pulmonary tuberculosis.

Bartacek A, Schütt D, Panosch B, Borek M; Rimstar 4-FDC Study Group.

Int J Tuberc Lung Dis. 2009 Jun;13(6):760-6.

PMID:
19460254
[PubMed - indexed for MEDLINE]
2.

[Effectiveness and problems of PZA-containing 6-month regimen for the treatment of new pulmonary tuberculosis patients].

Wada M.

Kekkaku. 2001 Jan;76(1):33-43. Review. Japanese.

PMID:
11211781
[PubMed - indexed for MEDLINE]
3.

Unilateral and painless development of isoniazid induced gynecomastia during re-treatment of pulmonary tuberculosis.

Kumar L, Gupta R, Puri MM, Jaiswal A, Srinath, Murar A, Behera D.

J Assoc Physicians India. 2011 Nov;59:733-5. Review.

PMID:
22616343
[PubMed - indexed for MEDLINE]
4.

[Short term treatment of infantile pulmonary tuberculosis].

Garciá López JR, Vidal López ML, Castán Vidal ML, Borque Andrés C, de José Gómez MI, García Hortelano J.

An Esp Pediatr. 1989 Aug;31(2):110-3. Review. Spanish.

PMID:
2696390
[PubMed - indexed for MEDLINE]
5.

Short-course drug therapy for tuberculosis.

Stratton MA, Reed MT.

Clin Pharm. 1986 Dec;5(12):977-87. Review.

PMID:
3542345
[PubMed - indexed for MEDLINE]
6.

Rifapentine vs. rifampicin for the treatment of pulmonary tuberculosis: a systematic review.

Gao XF, Li J, Yang ZW, Li YP.

Int J Tuberc Lung Dis. 2009 Jul;13(7):810-9. Review.

PMID:
19555529
[PubMed - indexed for MEDLINE]
7.

Rifapentine for the treatment of pulmonary tuberculosis.

Munsiff SS, Kambili C, Ahuja SD.

Clin Infect Dis. 2006 Dec 1;43(11):1468-75. Epub 2006 Oct 24. Review.

PMID:
17083024
[PubMed - indexed for MEDLINE]
Free Article
8.

New approaches to the treatment of latent tuberculosis.

Sterling TR.

Semin Respir Crit Care Med. 2008 Oct;29(5):532-41. doi: 10.1055/s-0028-1085704. Epub 2008 Sep 22. Review.

PMID:
18810686
[PubMed - indexed for MEDLINE]
9.

Treatment of tuberculous infection and disease in children: the North American perspective.

Stowe CD, Jacobs RF.

Paediatr Drugs. 1999 Oct-Dec;1(4):299-312. Review.

PMID:
10935428
[PubMed - indexed for MEDLINE]
10.

[Clinical practice guidelines from the Andalusian Society of Infectious Diseases (SAEI) for the treatment of tuberculosis].

Domínguez-Castellano A, Del Arco A, Canueto-Quintero J, Rivero-Román A, Kindelán JM, Creagh R, Díez-García F.

Enferm Infecc Microbiol Clin. 2007 Oct;25(8):519-34. Review. Spanish.

PMID:
17915111
[PubMed - indexed for MEDLINE]
11.

Fixed-dose combinations of antituberculous medications to prevent drug resistance.

Moulding T, Dutt AK, Reichman LB.

Ann Intern Med. 1995 Jun 15;122(12):951-4. Review.

PMID:
7755232
[PubMed - indexed for MEDLINE]
12.

[Perspective of pulmonary MAC infection treatment].

Kurashima A.

Kekkaku. 2007 Mar;82(3):195-9. Review. Japanese.

PMID:
17444124
[PubMed - indexed for MEDLINE]
13.

[Shortening of therapy duration in patients with pulmonary tuberculosis from 9 to 6 months only justifiable on the basis of published data].

van Loenhout-Rooyackers JH, Veen J, Verbeek AL.

Ned Tijdschr Geneeskd. 1996 Nov 2;140(44):2181-7. Review. Dutch.

PMID:
8984355
[PubMed - indexed for MEDLINE]
14.

[Case of endometrial tuberculosis].

Taniguchi H, Izumi S.

Kekkaku. 2005 Oct;80(10):643-6. Review. Japanese.

PMID:
16296392
[PubMed - indexed for MEDLINE]
15.

Ethambutol dosage for the treatment of children: literature review and recommendations.

Donald PR, Maher D, Maritz JS, Qazi S.

Int J Tuberc Lung Dis. 2006 Dec;10(12):1318-30. Review.

PMID:
17167947
[PubMed - indexed for MEDLINE]
16.

Antituberculosis drug-induced hepatotoxicity: concise up-to-date review.

Tostmann A, Boeree MJ, Aarnoutse RE, de Lange WC, van der Ven AJ, Dekhuijzen R.

J Gastroenterol Hepatol. 2008 Feb;23(2):192-202. Epub 2007 Nov 6. Review.

PMID:
17995946
[PubMed - indexed for MEDLINE]
17.

Duloxetine: a review of its use in the treatment of generalized anxiety disorder.

Carter NJ, McCormack PL.

CNS Drugs. 2009;23(6):523-41. doi: 10.2165/00023210-200923060-00006. Review.

PMID:
19480470
[PubMed - indexed for MEDLINE]
18.

[Adverse effects of antitubercular drugs: epidemiology, mechanisms, and patient management].

Aouam K, Chaabane A, Loussaïef C, Ben Romdhane F, Boughattas NA, Chakroun M.

Med Mal Infect. 2007 May;37(5):253-61. Epub 2007 Mar 1. Review. French.

PMID:
17336011
[PubMed - indexed for MEDLINE]
19.

A critical review of the probable reasons for the poor variable bioavailability of rifampicin from anti-tubercular fixed-dose combination (FDC) products, and the likely solutions to the problem.

Singh S, Mariappan TT, Shankar R, Sarda N, Singh B.

Int J Pharm. 2001 Oct 9;228(1-2):5-17. Review.

PMID:
11576764
[PubMed - indexed for MEDLINE]
20.

Tuberculosis and silicosis: epidemiology, diagnosis and chemoprophylaxis.

Barboza CE, Winter DH, Seiscento M, Santos Ude P, Terra Filho M.

J Bras Pneumol. 2008 Nov;34(11):959-66. Review. English, Portuguese.

PMID:
19099104
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk